Queen City Hills project unlikely to start in 2023 — but it’s still alive, principal says
A much-anticipated, major biotech project that was slated to be built at a key Uptown parcel is not expected to start this year, but a principal in the development said its partners are continuing to press forward on it.
The 5.85-acre Queen City Hills project, which was to include residential and commercial development as well as research labs, is in flux as it talks with potential biotech partners, said developer Eddie Rigaud.
Rigaud said the planned component parts of the development – biotech, manufacturing, housing, retail amenities, parking and green space – remain the same.
Rigaud recently attended the BIO Interantional Convention in Boston.
“We were able to encounter a lot of interest in coming to the Midwest from the coasts, which are very expensive,” Rigaud said. “We’re trying to figure out how that fits together and make sure we have the right plan for the site. We are working with a number of different entities looking at the site. There are some additional names that are entertaining (the possibility).”
In March, Cincinnati City Council rezoned the property to make way for the development. The project’s partners include Rigaud, his father, Cincinnati entrepreneur Ed Rigaud, and others, including David and Patricia Foxx.
Uptown Consortium, a community development organization funded by and consisting of the University of Cincinnati, the Cincinnati Zoo, Cincinnati Children’s Hospital Medical Center, TriHealth and UC Health, has played a major role in the development of the MLK/Reading corridor.
#cincinnati #nky #uptown #development #rezoned #orioerty #project #development #biotech #queencity #retail #construction #residential #cre #commercialrealestate #commercial #multifamily #apartments #restaurants #innovation